Depression and IL-6 Blood Plasma Concentrations in Advanced Cancer Patients

2008 ◽  
Vol 49 (1) ◽  
pp. 64-66 ◽  
Author(s):  
Colleen M. Jacobson ◽  
Barry Rosenfeld ◽  
Hayley Pessin ◽  
William Breitbart
2003 ◽  
Vol 17 (8) ◽  
pp. 673-678
Author(s):  
Masahiko Takahashi ◽  
Takeshi Ohara ◽  
Hiroyuki Yamanaka ◽  
Akira Shimada ◽  
Toshimichi Nakaho ◽  
...  

To provide additional pharmacokinetic evidence for the oral-to-parenteral relative potency ratio of 1:2 to 1:3 for chronic morphine use in a palliative care setting, we determined the plasma concentrations of morphine and its major metabolites, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G), in hospitalized advanced cancer patients maintained on long-term oral or intravenous morphine. There were significant linear correlations between daily doses of morphine and plasma concentrations (molar base) of morphine, M3G and M6G for both routes of administration. The oral-to-intravenous relative ratios of the regression coefficients were 2.9 for morphine and 1.8 for morphine» / M6G. The morphine kinetic variables were not significantly influenced by any hepato-renal biochemical markers. These results support the commonly used oral-to-intravenous relative potency ratio of 1:2 to 1:3 in patients with cancer pain receiving chronic morphine treatment.


Cancer ◽  
2002 ◽  
Vol 94 (12) ◽  
pp. 3247-3251 ◽  
Author(s):  
Elena M. V. de Cavanagh ◽  
Alba E. Honegger ◽  
Erica Hofer ◽  
Raul H. Bordenave ◽  
Eduardo O. Bullorsky ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document